Global In Vivo Toxicology Market, By Product (Consumables, Instruments), Testing Type (Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing), Toxicity Endpoints (Immuno toxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental and Reproductive Toxicity (DART), Other Toxicity Endpoints), Testing Facility (Outsourced Testing Facilities, In-House Testing Facilities) - Industry Trends and Forecast to 2030.
In Vivo Toxicology Market Analysis and Size
Regulatory requirements, growing R&D activities, and strategic initiatives by the key market players are some of the major factors expected to drive market growth. Furthermore, market players are expanding their product offerings to acquire a competitive advantage.
Data Bridge Market Research analyzes that the global in vivo toxicology market, which was USD 4,447.80 million in 2022, would rocket up to USD 6,877.91 million by 2030, and is expected to undergo a CAGR of 5.6% during the forecast period. “Consumables” dominates the product segment of the market owing to the increasing investment in healthcare.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
In Vivo Toxicology Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Year
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Product (Consumables, Instruments), Testing Type (Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing), Toxicity Endpoints (Immuno toxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental and Reproductive Toxicity (DART), Other Toxicity Endpoints), Testing Facility (Outsourced Testing Facilities, In-House Testing Facilities)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa
|
|
Market Players Covered
|
Thermo Fisher Scientific Inc. (U.S.), Danaher (U.S.), Charles River Laboratories. (U.S.), Covance Inc. (U.S.), THE JACKSON LABORATORY (U.S.), Data Sciences International (U.S.), Envigo (U.K.), Eurofins Scientific (Luxembourg), PerkinElmer Inc. (U.S.), SRI INTERNATIONAL (U.S.), Taconic Biosciences, Inc. (U.S.), Wuxi Apptec (China), Sigma-Aldrich Co. LLC. (U.S.), Catalent, Inc (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cyprotex (U.K.), MatTek (U.S.), XENOMETRIX AG (Switzerland), Quest Diagnostics Incorporated (U.S.), and Jubilant Life Sciences Company (India) among others
|
|
Market Opportunities
|
|
Market Definition
The global in vivo toxicology market refers to the market segment that involves the assessment and evaluation of the potential adverse effects of substances on living organisms, typically using animal models. In vivo toxicology studies are conducted to understand the safety and toxicological profiles of various substances, including pharmaceuticals, chemicals, pesticides, cosmetics, and other products. These studies aim to assess the impact of these substances on different organ systems, identify potential risks, and inform regulatory decision-making for product safety.
Global In Vivo Toxicology Market Dynamics
Drivers
- Regulatory Requirements
Stringent regulatory requirements for the safety assessment of pharmaceuticals, chemicals, and other products drive the demand for in vivo toxicology studies.
- Increasing R&D Activities
Growth in R&D activities in the pharmaceutical and chemical industries fuels the demand for in vivo toxicology studies to evaluate the safety profiles of new compounds.
- Advancements in Technology
Technological advancements in imaging techniques, such as in vivo imaging, provide enhanced capabilities for toxicology studies, leading to increased adoption.
Opportunity
- Shift toward Alternative Models
The increasing focus on replacing, reducing, or refining animal use in toxicology studies creates opportunities for the development and adoption of alternative models and methodologies. Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, the rising number of market players will further expand the market growth rate in the future.
Restraint/Challenge
- High Cost Associated with the Product Manufacturing
The high cost associated with product manufacturing, the disruption in the supply chain industry, the lack of favorable reimbursement scenarios and technology penetration in developing economies, and the lack of suitable infrastructure are projected to challenge the market growth in the forecast period of 2023-2030.
The global in vivo toxicology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Global In Vivo Toxicology Market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.
Recent Developments
- Covance Inc. offers a range of in vivo toxicology services and has been focusing on expanding its capabilities in predictive toxicology, including the integration of in silico and in vitro models.
- Charles River Laboratories International, Inc. is a leading provider of in vivo toxicology services and has been investing in advanced technologies, such as imaging and non-invasive monitoring, to enhance their toxicology capabilities.
Global In Vivo Toxicology Market Scope
The global in vivo toxicology market is segmented into four notable segments based on product, testing type, toxicity endpoints, and testing facility. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Consumables
- Instruments
Testing Type
- Chronic Toxicity Testing
- Sub-Chronic Toxicity Testing
- Sub-Acute Toxicity Testing
- Acute Toxicity Testing
Toxicity Endpoints
- Immuno Toxicity
- Systemic Toxicity
- Carcinogenicity
- Genotoxicity
- Developmental and Reproductive Toxicity (DART)
- Other Toxicity Endpoints
Testing Facility
- Outsourced Testing Facilities
- In-House Testing Facilities
Global In Vivo Toxicology Market Regional Analysis/Insights
The global in vivo toxicology market is analyzed, and market size insights and trends are provided by product, testing type, toxicity endpoints, and testing facility, as referenced above.
The countries covered in this market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa.
North America dominates the market due to factors including rising healthcare costs, increased R&D, and trending technological advancements.
Asia-Pacific is expected to witness the fastest growth during the forecast period of 2023 to 2030 due to the rising strategic initiatives by the key market players and favorable government initiatives in the region.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global in vivo toxicology market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2015-2020.
Competitive Landscape and Global In Vivo Toxicology Market Share Analysis
The global in vivo toxicology market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the global in vivo toxicology market are:
- Thermo Fisher Scientific Inc. (U.S.)
- Danaher (U.S.)
- Charles River Laboratories. (U.S.)
- Covance Inc. (U.S.)
- THE JACKSON LABORATORY (U.S.)
- Data Sciences International (U.S.)
- Envigo (U.K.)
- Eurofins Scientific (Luxembourg)
- PerkinElmer Inc. (U.S.)
- SRI INTERNATIONAL (U.S.)
- Taconic Biosciences, Inc. (U.S.)
- Wuxi Apptec (China)
- Sigma-Aldrich Co. LLC. (U.S.)
- Catalent, Inc (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Cyprotex (U.K.)
- MatTek (U.S.)
- XENOMETRIX AG (Switzerland)
- Quest Diagnostics Incorporated (U.S.)
- Jubilant Life Sciences Company (India)
SKU-